Edward Sarnowski — Chief Technology Officer at JenaValve Technology, Inc.

About Edward Sarnowski

Edward Sarnowski is Chief Technology Officer at JenaValve Technology, Inc. Location: Orange County, California, United States.

Skills

FDA
Management
Design Control

Additional experience

VP R&D, Structural Heart
Medtronic
December 2020 – May 2026

Education

MBA, MIT Sloan School of Management
Bachelor of Science, Massachusetts Institute of Technology

Current role

Title: Chief Technology Officer
Company: JenaValve Technology, Inc.
Location: Orange County, California, United States
Started: May 2026

About JenaValve Technology, Inc.

JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System is the first and only device currently approved in the EU for the treatment of severe, symptomatic aortic regurgitation in patients that are deemed high-risk for surgical aortic valve replacement. The Trilogy System is also CE-Mark approved for treatment of severe, symptomatic aortic stenosis. In the US, JenaValve has completed enrollment of the ALIGN-AR IDE Clinical Trial which will support a future PMA submission. If approved, the Trilogy System would become the first and only TAVR system in the US indicated for the treatment of symptomatic, severe AR. JenaValve is headquartered in Irvine, California with offices in Leeds, U.K. and Munich, Germany.

Industry: Medical Equipment Manufacturing
Company size: 51-200
Website: jenavalve.com

About Edward Sarnowski

Skills

Additional experience

VP R&D, Structural Heart

Education